Petros Pharmaceuticals Past Earnings Performance
Past criteria checks 0/6
Petros Pharmaceuticals has been growing earnings at an average annual rate of 17.4%, while the Pharmaceuticals industry saw earnings growing at 1% annually. Revenues have been declining at an average rate of 22.7% per year.
Key information
17.4%
Earnings growth rate
90.6%
EPS growth rate
| Pharmaceuticals Industry Growth | 6.0% |
| Revenue growth rate | -22.7% |
| Return on equity | -65.4% |
| Net Margin | -237.3% |
| Last Earnings Update | 31 Dec 2023 |
Revenue & Expenses BreakdownBeta
How Petros Pharmaceuticals makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 6 | -14 | 9 | 2 |
| 30 Sep 23 | 7 | -13 | 9 | 2 |
| 30 Jun 23 | 4 | -22 | 9 | 2 |
| 31 Mar 23 | 6 | -21 | 10 | 2 |
| 31 Dec 22 | 6 | -20 | 12 | 2 |
| 30 Sep 22 | 4 | -24 | 13 | 3 |
| 30 Jun 22 | 8 | -12 | 15 | 2 |
| 31 Mar 22 | 6 | -12 | 16 | 2 |
| 31 Dec 21 | 8 | -9 | 16 | 2 |
| 30 Sep 21 | 12 | -6 | 15 | 1 |
| 30 Jun 21 | 13 | -8 | 15 | 1 |
| 31 Mar 21 | 12 | -11 | 15 | 0 |
| 31 Dec 20 | 10 | -21 | 16 | 0 |
| 30 Sep 20 | 9 | -24 | 16 | 0 |
| 30 Jun 20 | 10 | -29 | 19 | 0 |
| 31 Mar 20 | 12 | -32 | 20 | 0 |
| 31 Dec 19 | 16 | -33 | 20 | 0 |
| 31 Dec 18 | 14 | -32 | 11 | 0 |
Quality Earnings: PTPI is currently unprofitable.
Growing Profit Margin: PTPI is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: PTPI is unprofitable, but has reduced losses over the past 5 years at a rate of 17.4% per year.
Accelerating Growth: Unable to compare PTPI's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: PTPI is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (-13.2%).
Return on Equity
High ROE: PTPI has a negative Return on Equity (-65.41%), as it is currently unprofitable.